Rising Payor Influence Means Successful Drug Launches are Rarer

Growing payor influence on the uptake of high-price products is making successful drug launches far harder to achieve. Payor power varies from one Western market to the next, but all are moving in the same direction, with weakening prescriber clout and thus also less impact from detailing on launch success.

By Sarah Rickwood

Already struggling with the fact that it lacks sufficient new products to replace current best sellers that are losing patent...

More from Archive

More from In Vivo